Translational Neurosciences Center Innovations
The Translational Neurosciences Center is funded by a variety of extramural sources including the NIH and other health care agencies, as well as grants and contracts from corporate and philanthropic organizations. Research is currently being conducted in the following areas:
- In models of stroke, researchers have identified new molecules in the brain that have a neuroprotective function. These, or related molecules, may prove useful in future
- stroke treatment.
- Researchers have discovered that drugs used for other treatments stop the growth of some brain tumor cells. These drugs are now being tested in neurological clinical trials.
- Investigators in the center are developing new insights into how to maintain viable neurons after ischemic insults. Several new targets have been identified and will be developed to determine whether they are drug-treatable.
- A novel project defining the responses of the embryonic and newborn brain to inflammation, prematurity and ischemia is identifying new strategies for treating babies with these problems.
- Stem cell therapies for multiple sclerosis and stroke are in development. Our research efforts coordinate with or are parallel to many NIH studies. We welcome inquiries from potential collaborators.
Current Translational Neurosciences Center Clinical Trials
Center investigators use genetic, cellular and molecular analyses to investigate the ways in which the nervous system processes information and which dysfunctions lead to the many kinds of neurological diseases and conditions, including, Stroke, Brain tumors, Multiple sclerosis, Spinal cord injury and Alzheimer’s disease.